Signal Peptide Database - Mammalia

 Entry Details
ID   275
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   O75460    (Created: 2004-08-16 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name   ERN1_HUMAN
Protein Name   Serine/threonine-protein kinase/endoribonuclease IRE1
Gene   ERN1
Organism Scientific   Homo sapiens
Organism Common   Human
Lineage   Eukaryota
  Metazoa
    Chordata
      Craniata
        Vertebrata
          Euteleostomi
            Mammalia
              Eutheria
                Euarchontoglires
                  Primates
                    Haplorrhini
                      Catarrhini
                        Hominidae
                          Homo
Protein Length [aa]   977
Protein Mass [Da]   109735
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   18
chain   Serine/threonine-protein kinase/endoribonuclease IRE1      19   977
transmembrane region      potential   444   464
topological domain   Lumenal   potential   19   443
topological domain   Cytoplasmic   potential   465   977
domain   Protein kinase      571   832
domain   KEN      835   963
glycosylation site   N-linked (GlcNAc...)   potential   176   176
sequence variant   (in a lung adenocarcinoma sample; somatic mutation)      0   0
sequence variant   (in dbSNP:rs55869215)      0   0
sequence variant   (in a renal clear cell carcinoma sample; somatic mutation)      0   0
sequence variant         0   0
sequence variant   (in a glioblastoma multiforme sample; somatic mutation)      0   0
sequence variant   (in an ovarian serous carcinoma sample; somatic mutation)      0   0
sequence variant   (in a gastric adenocarcinoma sample; somatic mutation)      0   0
strand         32   37
strand         40   46
strand         52   57
strand         73   75
strand         82   84
strand         93   95
strand         120   128
strand         154   164
strand         168   172
strand         176   182
strand         197   201
strand         205   209
strand         216   221
strand         226   231
strand         238   240
strand         243   246
strand         280   284
strand         286   288
strand         297   300
helix         100   104
helix         247   264
helix         273   279
active site   Proton acceptor   by similarity   688   688
splice variant   (in isoform 2)      0   0
splice variant   (in isoform 2)      71   977
binding site   ATP      599   599
nucleotide phosphate-binding region   ATP   by similarity   577   585
mutagenesis site   Loss of autophosphorylation and of endoribonuclease activity. Inhibition of growth arrest      0   0
mutagenesis site   No effect on dimerization. Weakens dimer; when associated with S-332      0   0
mutagenesis site   No effect on dimerization. Weakens dimer; when associated with S-148      0   0
mutagenesis site   No effect on dimerization      0   0
turn         47   49
turn         77   79
turn         211   213
turn         359   361
SP Length   18
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MPARRLLLLLTLLLPGLG
Sequence MPARRLLLLLTLLLPGLGIFGSTSTVTLPETLLFVSTLDGSLHAVSKRTG
S
IKWTLKEDPVLQVPTHVEEPAFLPDPNDGSLYTLGSKNNEGLTKLPFTI
PELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQTLSSAFADSLCPS
TSLLYLGRTEYTITMYDTKTRELRWNATYFDYAASLPEDDVDYKMSHFVS
NGDGLVVTVD
SESGDVLWIQNYASPVVAFYVWQREGLRKVMHINVAVETL
RYLTFMSGEVGRITKWKYPFPKETEAKSKLTPTLYVGKYSTSLYASPSMV
HEGVAVVPRGSTLPLLEGPQTDGVTIGDKGECVITPSTDVKFDPGLKSKN
KLNYLRNY
WLLIGHHETPLSASTKMLERFPNNLPKHRENVIPADSEKKSF
EEVINLVDQTSENAPTTVSRDVEEKPAHAPARPEAPVDSMLKDMATIILS
TFLLIGWVAFIITYPLSMHQQQQLQHQQFQKELEKIQLLQQQQQQLPFHP
PGDTAQDGELLDTSGPYSESSGTSSPSTSPRASNHSLCSGSSASKAGSSP
SLEQDDGDEETSVVIVGKISFCPKDV
LGHGAEGTIVYRGMFDNRDVAVKR
ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQ
EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN
AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN
PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH
EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIE
KESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDL
LRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMEL
CSHERLFQPYYFHEPPEPQPPVTPDAL
Original MPARRLLLLLTLLLPGLGIFGSTSTVTLPETLLFVSTLDGSLHAVSKRTG
SIKWTLKEDPVLQVPTHVEEPAFLPDPNDGSLYTLGSKNNEGLTKLPFTI
PELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQTLSSAFADSLCPS
TSLLYLGRTEYTITMYDTKTRELRWNATYFDYAASLPEDDVDYKMSHFVS
NGDGLVVTVDSESGDVLWIQNYASPVVAFYVWQREGLRKVMHINVAVETL
RYLTFMSGEVGRITKWKYPFPKETEAKSKLTPTLYVGKYSTSLYASPSMV
HEGVAVVPRGSTLPLLEGPQTDGVTIGDKGECVITPSTDVKFDPGLKSKN
KLNYLRNYWLLIGHHETPLSASTKMLERFPNNLPKHRENVIPADSEKKSF
EEVINLVDQTSENAPTTVSRDVEEKPAHAPARPEAPVDSMLKDMATIILS
TFLLIGWVAFIITYPLSMHQQQQLQHQQFQKELEKIQLLQQQQQQLPFHP
PGDTAQDGELLDTSGPYSESSGTSSPSTSPRASNHSLCSGSSASKAGSSP
SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR
ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQ
EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN
AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN
PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH
EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIE
KESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDL
LRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMEL
CSHERLFQPYYFHEPPEPQPPVTPDAL
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11